AAMDSIF Letter Supporting HR 4215, The Patient Access to Cellular Transplant Act | Aplastic Anemia and MDS International Foundation

AAMDSIF Letter Supporting HR 4215, The Patient Access to Cellular Transplant Act

Original Publication Date: 
Thursday, January 11, 2018
Article Source: 
AAMDSIF Research Review

CEO Kathleen Weis expresses full support by AAMDSIF for HR 4215, the The Patient Access to Cellular Transplant (PACT) Act.

HR4215 provides that Medicare would remiburse stem cell, bone marrow, and cord blood transplants at the same rate as other transplants.